TTNP - titanpharm.com Sales Growth YoY (TTM)

Graphic logo of titanpharm.com (TTNP)

Titan Pharmaceuticals relies on the expertise of biochemists in developing extended-release drug delivery systems. However, litigation and a shortage of funds for innovation create serious risks. The rolling 12-month revenue growth trend on the GURU.Markets chart visualizes this crisis, where -46.40 shows the value of this parameter. Currently, the company lacks pricing power and is seeking ways to survive amid restructuring.

Titan Pharmaceuticals (TTNP) - Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 02/20/2024

Titan Pharmaceuticals (TTNP) - metric breakdowns and financial figures

- current price and projected stock value:
Summary company analytics:TTNP (Titan Pharmaceuticals, Inc.)
Finished products of Titan Pharma

Portfolio managers evaluate the operating model of Titan Pharmaceuticals (TTNP) through revenue dynamics over the last 12 months, calculated via a daily comparison of current annual turnover against the same period last year to eliminate accounting distortions. By analyzing the TTM revenue growth trajectory compared to the previous year, an investor can gauge the real effectiveness of licensing agreements and the stability of partnerships within the drug delivery systems sector.